The International Online Journal of Cancer & Therapeutics is a peer-reviewed open acess journal that publishes original research articles as well as review articles in all areas of Oncology. this practical journal also includes information on new products, new therapies and patient management, as well as reviews of the latest research. Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences The International Online Journal of Cancer & Therapeutics exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients.

The journal publishes important original studies, reviews, and perspectives within the major topic areas of biology of premalignancy, risk factors and risk assessment, early detection research, immunoprevention, and chemopreventive and other interventions, including the basic science behind them. This journal comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

Oncology is the diagnosis and treatment of cancers,including breast,prostate,colon,lung and ovarian cancers as well as brain tumors,leukemia,lymphoma and many other types of cancer.. A doctor who works in the field of oncology is called an oncologist. The primary regions of oncology are radiation, which is worried with radiation treatment, or radiotherapy; surgical, which is contained specialists who spend significant time in tumor evacuation; therapeutic, which manages disease drugs, including chemotherapy; and interventional, which includes interventional radiologists who have some expertise in insignificantly obtrusive picture guided tumor treatment.


committee

Members

ThumbnailImage

Mohamed Ismail Nounou

Assistant Professor

Dr. Mohamed Ismail Nounou is a pharmaceutical formulator, medicinal chemist and genetic engineer.He has completed his Ph.D from University of Houston on 2011 and postdoctoral studies from Texas Tech. University Health Sciences Center. He is currently an assistant professor of Pharmaceutics, atAlexandria University, School of Pharmacy (Egypt) and Department of Pharmaceutical Sciences at University of Saint Joseph (USA). He has published more than 30 papers in reputed journals and serving as an editorial board member and reviewer of over five reputable research journals. He currently workon three different research topics, brain drug delivery, nonverbal gene delivery and quality of pharmaceuticals, nutraceuticals and cosmeceuticals. Currently, his research lab. includes over ten master degree students and two Ph.D. students.
 

  • More than 10 years of research experience involving targeted drug delivery, brain drug delivery, CNS & brain cancers and metastases, in-vitro and in-vivo modeling of Blood Brain Barrier (BBB) and Blood Tumor Barrier (BTB), cell culture techniques for cancer, pluripotent and stem cells, pharmaceutical bio-conjugation, polymeric and peptidomemetic structures design and anti-cancer drug evaluation. Profound expertise in developing various formulations inclusive of topical and vesicular drug delivery systems, evaluation of pharmaceutical products quality, adulteration and counterfeiting of nutraceutical formulations as well as in-vitro/in-vivo formulations evaluation. Demonstrates expertise in pharmaceutical polymer chemistry and non-viral gene delivery. Known for versatility and effectiveness in stressful situations; demonstrates “big picture” vision and sensitivity to bottom-line in order to deliver high-quality projects and tasks. Responds quickly and properly to changing circumstances; assesses problems and formulates comprehensive decisions to achieve positive change. Highly motivated creative thinker with strong data interpretation and problem solving abilities. Effective oral and written communication skills.
  • My current research projects involve performing experiments utilizing both in-vitro and in-vivo models of the blood brain barrier, eventually assisting in the development of smart bioconjugate and nanoparticluate formulations for delivery across the blood brain barrier.
  • 2014: Erasmus Mundis Action 2 “Al Idrisi” Grant (2013-2401/001-001-EMA2).
  • 2010: University of Houston, College of Pharmacy Scholarship.
  • 2009: Dr. Bhagavan Jandhyala Endowed Scholarship.
  • 2009: International Polyolefin Conference and the Division of Polymer Additives and Modifier of the Society of Plastic Engineers Scholarship.
  • 2008: Dr. Bhagavan Jandhyala Endowed Scholarship.
  • 2006: Ph.D. Grant from the Egyptian government.
  • Journal of Cancer Metastasis and Treatment (JCMT)
  • Breast cancer: Clinics in Oncology
  • Journal of Clinical Breast Cancer Research
  •  Over 40 peer-review publications